Hypopituitarism after traumatic brain injury.

Area of Science:

• Neuroendocrinology
• Traumatic Brain Injury Research

Background:

• Hypopituitarism is a potential complication following traumatic brain injury (TBI).
• Literature reports variable prevalence rates for hypopituitarism post-TBI.
• Anterior hypopituitarism has a pooled prevalence of 27.5% in TBI patients.

Purpose of the Study:

• To summarize the prevalence of hypopituitarism after TBI.
• To highlight growth hormone deficiency as the most common pituitary insufficiency.
• To review the impact of substitution therapy on cognitive outcomes in TBI patients with GH deficiency.

Main Methods:

• Meta-analysis of existing literature on hypopituitarism prevalence after TBI.
• Review of studies investigating hormone deficiencies and their relationship with TBI severity and diagnostic assays.
• Analysis of recent research on the effects of growth hormone (GH) substitution therapy.

Main Results:

• A meta-analysis found a pooled prevalence of 27.5% for anterior hypopituitarism post-TBI.
• Growth hormone deficiency is the most frequent pituitary hormone insufficiency observed.
• Diagnostic assays, TBI severity, and evaluation timing influence prevalence rates.
• Substitution therapy in GH-deficient TBI patients shows promise for improving cognitive function and quality of life.

Conclusions:

• Hypopituitarism is a significant concern after TBI, with anterior pituitary dysfunction affecting over a quarter of patients.
• Growth hormone deficiency is the primary endocrine deficit, warranting careful monitoring and management.
• Hormone replacement therapy, particularly for GH deficiency, may offer therapeutic benefits for cognitive impairments in TBI survivors.